Revenue: The sum of all revenue fields included for a company's operating activities.
Lexicon Pharmaceuticals, Inc. (LXRX) had Revenue of $28.87M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$28.87M |
$3.25M |
|
$0.03M |
|
$28.83M |
|
$25.13M |
|
$3.74M |
|
$-0.48M |
|
$3.25M |
|
$3.25M |
|
$3.25M |
|
$3.25M |
|
$3.25M |
|
$3.25M |
|
$3.74M |
|
$4.31M |
|
363.29M |
|
363.57M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$145.08M |
|
$2.13M |
|
$80.50M |
|
$225.58M |
|
$34.84M |
|
$56.11M |
|
$61.31M |
|
$96.14M |
|
$129.44M |
|
$84.90M |
|
$129.44M |
|
363.40M |
|
| Cash Flow Statement Financials | |
$-26.79M |
|
$56.06M |
|
$-45.57M |
|
$66.66M |
|
$50.36M |
|
$-16.29M |
|
$6.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
0.30 |
|
0.43 |
|
99.89% |
|
12.94% |
|
12.94% |
|
-- |
|
11.27% |
|
11.27% |
|
$-26.79M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.20 |
|
13.22 |
|
6.81 |
|
2.51% |
|
3.83% |
|
1.44% |
|
1.75% |
|
$0.36 |
|
$-0.07 |
|
$-0.07 |
|